KLRS- Kalaris Therapeutics, Inc.

Name: Kalaris Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kalaris Therapeutics, Inc. (KLRS) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 33 sells. KLRS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Akkaraju Srinivas	2.22M	$9.79M	-
CFO	Gall Matthew	235.0K	$1.03M	-

Activity

Buys and sells only

Transactions

10 filings · page 16

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 9, 2021	Jovan-Embiricos Morana87	Director	Sell	12,196	$24.80	$302,455.17	-0.4%	-66.7%	-71.2%
Oct 27, 2021	Jovan-Embiricos Morana87	Director	Sell	2,200	$24.78	$54,510.50	-0.1%	-66.0%	-73.4%
Oct 25, 2021	Jovan-Embiricos Morana87	Director	Sell	13,592	$24.80	$337,045.37	-0.3%	-66.5%	-72.0%
Oct 21, 2021	Atillasoy Ercem78	See Remarks	Sell	1,514	$24.23	$36,690.43	-1.4%	-64.7%	-65.5%
Oct 4, 2021	Melian Agustin83	Chief Medical Officer	Sell	18,689	$23.91	$446,861.73	-1.0%	-40.8%	-61.6%
Oct 1, 2021	Van Beek Jeroen B85	Chief Commercial Officer	Sell	16,584	$25.14	$416,905.70	-1.3%	-48.0%	-69.6%
Sep 28, 2021	Melian Agustin83	Chief Medical Officer	Sell	3,750	$24.12	$90,432.38	-0.8%	-45.6%	-66.4%
Sep 17, 2021	Melian Agustin83	Chief Medical Officer	Sell	40,548	$22.11	$896,684.71	-2.1%	-39.4%	-66.0%
Sep 17, 2021	Van Beek Jeroen B85	Chief Commercial Officer	Sell	53,051	$26.57	$1,409,645.64	-1.6%	-39.4%	-66.0%
May 10, 2021	Leen Ann M.83	Chief Scientific Officer	Sell	150,000	$22.75	$3,412,500.00	-6.1%	-2.7%	-82.9%

← PrevPage 16Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC